Pfizer, Anthropic and longevity scientists position AI as healthcare's core infrastructure, accelerating drug design and care ...

Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor Starboard Value, saying he agreed with some of ...

Pfizer Inc. chief executive Albert Bourla praised the Trump administration’s latest pick to lead the Centers for Disease Control and Prevention after vaccine policy was upended in the past year.

As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, ...

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Pfizer has been leaning on recently acquired products to offset a looming patent cliff.